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Abstract G protein-activated K+ channel (GIRK) subunits
possess a conserved extracellular integrin-binding motif (RGD)
and bind directly to L1 integrins. We expressed GIRK1/GIRK4
channels labeled with green fluorescent protein in fibroblast cell
lines expressing or lacking L1 integrins. Neither plasma
membrane localization nor agonist-evoked GIRK currents were
affected by the absence of L1 integrins or by incubation with
externally applied RGD-containing peptide. Mutation of the
aspartate (D) of RGD impaired currents, GIRK glycosylation,
and membrane localization, but the interaction with L1 integrins
remained intact. Thus, L1 integrins are not essential for
functional GIRK expression; and the GIRK-integrin interactions
involve structural elements other than the RGD motif.
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1. Introduction
Integrins are a large family of transmembrane adhesive re-
ceptors that mediate interactions both with the extracellular
matrix and with neighboring cells. Integrin receptors are KL
heterodimers with a transmembrane segment, a short cyto-
plasmic domain, and a longer extracellular domain [1]. The
extracellular ligand-binding domain in many cases recognizes
a conserved RGD sequence on adhesion proteins [2,3], while
the cytoplasmic domains interact with the cytoskeleton [1].
Besides acting as physical links between molecules in the
extracellular matrix and the cytoskeleton, integrins function
as transducers of various cellular signals [4]. The transduction
pathways are initiated by interactions of integrins with extra-
cellular matrix or cell surface ligands and include activation of
tyrosine kinases [5], protein kinase C, MAP kinases [6^8], and
modulation of membrane ion conductances [4]. Integrins are
involved in the regulation of many cellular functions, includ-
ing cell adhesion, proliferation, di¡erentiation, migration,
growth, and alteration of gene expression [1,9^11].
Integrin signaling pathways may participate in modulation
of K channel function. Integrin-ligand interactions enhance
K conductance, leading to membrane hyperpolarization in
neuroblastoma and erythroleukemia cells after interaction
with ¢bronectin [12,13]. The synthetic RGD-containing pep-
tides that bind the KvL3 integrins expressed by the vascular
smooth muscle cause pronounced vasodilation in rat skeletal
muscle arterioles [14]. Recently it was shown that an RGD-
containing peptide, presumably working through K5L3, acti-
vates K e¥ux from vascular smooth muscle cells, causing
hyperpolarization and subsequent inactivation of voltage-
gated Ca2 channels and leading to a decrease in Ca2 levels
and to vasodilation [15].
G protein-activated K channels (GIRKs) mediate the para-
sympathetic inhibition of heart rate and the inhibitory e¡ects
of many neurotransmitters in the brain [16]. In the heart,
GIRK channels are activated by acetylcholine (ACh) via the
muscarinic m2 receptor (m2R) and pertussis toxin-sensitive G
proteins [17,18]. Cardiac GIRK is normally a heterotetramer
of stoichiometry GIRK12/GIRK42. All known GIRK
(Kir3.x) subunits, but no other known ion channels, have a
conserved peptide sequence RGD on their extracellular sur-
face between the putative ¢rst membrane spanning region
(M1) and the P region. It has been shown recently that
GIRK1 and GIRK4 channel subunits bind directly to L1 in-
tegrins and that mutation of the aspartate (D) of the integrin-
binding RGD sequence of GIRK4 (and, to a lesser extent, of
GIRK1) abolishes functional GIRK expression in Xenopus
oocytes [19]. To extend this observation, we compared the
expression and subcellular distribution of heteromultimeric
GIRK1/4 channels in two mouse ¢broblast cell lines: one
expressing the L1A splice variant, and the other (GD10) lack-
ing L1 integrins due to the disruption of the L1 integrin sub-
unit gene [20]. Using chimeric constructs of GIRK with the
£uorescent green protein (GFP), we observed similar plasma
membrane localization of heteromultimeric GIRK1/4 chan-
nels in cell lines both with and without L1 integrins, and we
observed no di¡erences in the magnitude of GIRK currents in
the two cell lines. The results indicate that GIRK1/4 inward
recti¢er channels do not require L1 integrins for expression
and function.
2. Materials and methods
2.1. Materials
GIRK1 antibody was raised in rabbits against a peptide from the
C-terminus of rat GIRK1 [21]. The integrin antibody was raised in
rabbits against the C-terminus of chick L1 integrin (a gift of Dr.
Richard Hynes) [22]. Restriction enzymes were from New England
Biolabs. Other reagents were from Sigma, including the RGDS pep-
tide (Cat. #A 9041).
Four cDNA constructs ^ GIRK1 WT (wild-type), GIRK4 WT, and
their mutants in which the RGD sequences of the protein were
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changed to RGE ^ were subcloned into pMXT [19]. RNA was tran-
scribed in vitro using the mMessage Machine kit (Ambion).
For the construction of the GIRK-GFP chimeras, the stop codon
was removed and a NotI site was introduced at the 3P end of the
coding sequences of GIRK1 WT, GIRK4 WT, GIRK1 D111E, and
GIRK4 D117E using the polymerase chain reaction (PCR). The re-
sulting constructs were ligated into pcDNA3.1 containing the GFP
coding sequence so that the latter was fused in-frame to the 3P end of
the GIRK subunits. To determine whether the addition of GFP to the
C-terminus of the GIRKs has any e¡ect on the channel function, two-
electrode voltage-clamp experiments were performed to measure cur-
rent in Xenopus oocytes expressing these construct. No di¡erences in
function were detected between WT channels and those containing the
GFP sequences.
2.2. Metabolic labeling with [35S]methionine and
co-immunoprecipitation
This was performed as described [23]. Oocytes were injected with
GIRK1/4 WT and GIRK1/4(RGDCRGE) mutant cRNAs (5 ng
each subunit per oocyte) and incubated in ND96, containing
0.5 mCi/ml [35S]methionine (Amersham Pharmacia Biotech) for
3 days at 22‡C. Plasma membranes together with the vitelline mem-
branes (extracellular collagen-like matrix) were removed manually
with ¢ne forceps after a 5^10 min incubation in a low osmolarity
solution. The remainder of the cell, consisting of cytoplasm and intra-
cellular organelles (‘internal fraction’) was processed separately.
Thirty plasma membranes and 30 internal fractions were homogenized
separately for 10 min on ice in 300 Wl of lysis bu¡er (150 mM NaCl,
1 mM MgCl2, 50 mM Tris, pH 7.6, 1% CHAPS, 1 mM phenyl-
methylsulfonyl£uoride and 2 Wg/ml each of leupeptin, pepstatin and
aprotinin). Insoluble material was removed by centrifugation for 1 min
at 16 000Ug, 4‡C. The supernatant was precleared by incubation at
4‡C with protein G-Sepharose (Amersham Pharmacia Biotech) for 1 h.
Sepharose was removed by 20 s centrifugation in a Picofuge (Strata-
gene). Primary antibody (GIRK1 or anti-chick integrin L1) and pro-
tein G-Sepharose were added to the precleared lysate and incubated
for 3 h at 4‡C and pelleted. Immunoprecipitates were washed 4 times
with 1 ml of lysis bu¡er. Samples were boiled in SDS-gel loading
bu¡er and electrophoresed on 10% polyacrylamide-SDS gel.
2.3. Oocyte expression and electrophysiology
These procedures have been described [19]. Injected oocytes were
incubated for 3 days in ND96 solution (96 mM NaCl, 2 mM KCl,
1 mM CaCl2, 1 mM MgCl2, 5 mM HEPES, pH 7.5) supplemented
with 2.5 mM sodium pyruvate and 50 Wg/ml gentamicin. The initial
recording solution was a high Na solution containing 98 mM NaCl,
1 mM MgCl2, 5 mM HEPES, pH 7.5. To record inward GIRK
currents, the solution was changed to one containing 98 mM KCl
in place of NaCl. To activate the GIRK currents via the m2R,
1 WM ACh was included. GIRK1/4 currents were recorded using a
voltage ramp from 380 to +30 mV from a holding potential of 380
mV.
2.4. Cell culture and transfection
The L1-null mouse ¢broblast cell line GD10, which lacks expression
of L1 integrin due to disruption of the L1 integrin subunit gene, and a
control GD10 line expressing the L1A splice variant of L1 integrin
were employed [20]. GD10 cells were cultured in DME+10% fetal
Fig. 1. Subcellular distribution of GFP-tagged GIRK1/4 subunits in control ¢broblasts and in GD10 L1-null cells. A: Control ¢broblasts with
L1 integrin, transfected with GFP alone. Note the di¡use cytoplasmic £uorescence. B: Control ¢broblasts transfected with WT GIRK1/4. Note
the plasma membrane localization of £uorescence. C: GD10 L1-null ¢broblasts transfected with WT GIRK1/4. Note the plasma membrane lo-
calization of £uorescence. D: Control ¢broblasts after transfection with GIRK1/4(RGDCRGE) mutant. The GFP £uorescence does not reach
the plasma membrane. Scale bar represents 25 Wm in A, B and 15 Wm in C, D.
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bovine serum+L-glutamine (2 mM)+penicillin-streptomycin (non-se-
lection medium). L1 integrin-expressing cell lines were continuously
cultured in the same medium with puromycin (10 Wg/ml) (selection
medium). Cells were transiently transfected using E¡ectene (Qiagen)
according to the manufacturer’s instructions. For microscopy, 1 ng
each of cDNA for GIRK1-GFP and GIRK4-GFP were transfected;
for electrophysiology, 1 ng of cDNA for m2R was cotransfected in
addition. All constructs were in pcDNA3.1. For experiments with the
RGDS peptide, 0.4 mM peptide was included in the medium 2 h after
transfection. Confocal microscopy and voltage-clamp recordings were
performed 2 days after transfection.
2.5. Electrophysiology on ¢broblasts
Recordings were begun in extracellular recording saline (mM):
NaCl 140, KCl 5.4, CaCl2 2, MgCl2 1, HEPES 10, D-glucose 30,
pH 7.4. To elicit GIRK currents, the external solution was changed
to one containing 25 mM KCl in place of 25 mM NaCl. Single-cell
recording was performed at 21^24‡C with pipettes pulled in four
stages from 1.5 mm o.d. glass capillary tubes (WPI, Sarasota, FL,
USA) with a P80/PC micropipette puller (Sutter Instruments, Novato,
CA, USA). Patch pipettes were ¢lled with a solution containing
(mM): KCl 140, MgCl2 2, HEPES 5, EGTA 0.6, ATP 4, GTP 0.2,
CaCl2 0.06, pH 7.4. Ionic currents were measured with a patch-clamp
ampli¢er (Axopatch 200, Axon Instruments, Foster City, CA, USA),
¢ltered at 2 kHz, digitized at 10 kHz, recorded on a computer
(pCLAMP 7, Axon Instruments) and monitored on both a storage
oscilloscope and a chart recorder. Pipette resistance ranged from 2 to
5 M6 when ¢lled with internal solution. Cells were voltage-clamped
at a holding potential of 380 mV. Cells were chosen for study based
on £uorescence of a transfected GFP reporter construct. Series resist-
ance was monitored by measuring the instantaneous current in re-
sponse to a 5 mV voltage step command. Results were discarded if
the series resistance changed by more than 10% during the course of
an experiment. The drugs were applied by a local perfusion system in
which up to six solutions were connected to one port. The port fed a
delivery tube (250 WM internal diameter) mountedV500 Wm from the
recorded cell ; £ow rate was V0.5 ml/min and changes among the
solutions occurred within 2 s.
Fig. 2. GIRK currents in control and L1-null ¢broblasts. Current-voltage relations were measured in the presence of KCl (25 mM) and in the
presence of KCl+ACh (5 WM). Background current was blocked by Ba2 (200 WM) and subtracted from traces in the absence of Ba2 ; result-
ing traces are plotted. A: Typical data for a control cell ; B: L1-null ¢broblast; C: control cell transfected with RGDCRGE mutant. D: Aver-
age currents induced by KCl (25 mM) and KCl+ACh (5 WM) for control and L1-null ¢broblasts expressing WT GIRK1/4 and for control ¢-
broblasts transfected with GIRK1/4(RGDCRGE). Currents were measured day 2 after cotransfection of the indicated ¢broblast cell line with
the GIRK1/GIRK4 heteromultimer channel and a GFP reporter plasmid. For measurement, cells were voltage-clamped at a holding potential
of 380 mV and a voltage ramp (3150 mV to +60 mV) was used. Mean peak amplitudes of KCl and KCl+ACh-induced current were ana-
lyzed. Data represent mean þ S.E.M. of 10 control and 11 L1-null cells from three independent experiments.
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3. Results
3.1. Distribution of GIRK1/4 WT-GFP and
GIRK1/4(RGDCRGE)-GFP in GD10 cells
To study the role of the L1 integrins for expression and
function of GIRK1/4 channels, we used the L1 integrin-de¢-
cient mouse ¢broblast GD10 cell line. Because these cells do
not express L1 integrins, we could directly determine whether
heteromultimeric GIRK1/GIRK4 channel requires L1 integrin
for proper function. We compared the expression level and
localization of GIRK1/4 WT channel in two lines of ¢bro-
blasts ^ one expressing L1 integrins, and the other lacking
expression of these proteins. We fused GFP in-frame to C-
termini of GIRK1 and GIRK4 subunits and examined the
localization of the labeled protein using a confocal micro-
scope. In ¢broblasts transfected with GFP-pcDNA3.1 alone,
only a di¡use weak £uorescent background was seen (Fig.
1A). In ¢broblasts expressing L1 integrins, the expressed
GIRK1/4-GFP WT channels showed clear plasma membrane
localization of £uorescence (Fig. 1B). In ¢broblasts lacking L1
integrins, the strong plasma membrane signal was similarly
obtained after transfection with GIRK1-GFP and GIRK4-
GFP (Fig. 1C). This suggests that GIRK channels can reach
the plasma membrane in cells lacking L1 integrins. In contrast
to the distribution of the GIRK1/4-GFP WT channel, plasma
membrane £uorescence of GFP fusions with RGDCRGE
was less bright, and there was greater £uorescence in the en-
doplasmic reticulum and Golgi complex, indicating that the
RGDCRGE mutant does not reach the plasma membrane
but remains localized in the endoplasmic reticulum and Golgi
complex (Fig. 1D).
3.2. GIRK currents in control and L1-null ¢broblasts
The two lines of ¢broblasts coexpressing GIRK1/4 and the
muscarinic m2 receptors were also studied in voltage-clamp
experiments to characterize the functionality of the expressed
channels by monitoring the K current of these channels. To
measure basal GIRK currents, the initial low K perfusion
solution was changed to a high K (25 mM KCl solution);
the coexpressed m2R was then activated by application of
5 WM ACh in high K solution. Current-voltage relations
were obtained using a voltage ramp (3150 to +60 mV). Rep-
resentative current-voltage relations for ACh-activated
GIRK1/4 current in wild-type and in L1-null ¢broblasts are
shown in Fig. 2A and B, respectively. The basal and ACh-
activated K currents typically showed inward recti¢cation
and were completely blocked by the application of external
Ba2 (0.2 mM, not shown). At 380 mV, currents induced by
ACh were 766 þ 214 pAî in cells expressing L1 integrins and
588 þ 99 pAî in cells without L1 integrins (mean þ S.E.M.,
n = 10 or 11). There also was no signi¢cant di¡erence in basal
GIRK currents (Fig. 2). Fig. 2C con¢rms that the
RGDCRGE mutant produces no detectable GIRK currents
in ¢broblasts, as previously reported for CHO cells. There was
no signi¢cant di¡erence in whole-cell capacitance between
control and L1-null cells.
3.3. External application of RGD peptide
Because L1-null ¢broblasts express KvL3 and KvL5 [24]
which also recognize the RGD sequence, it was possible
that these integrins could be involved in the interaction with
GIRK1/4 channels. In order to examine this possibility, we
used the RGDS peptide to disrupt this interaction. This
RGDS-containing peptide is known to bind to integrins, com-
petitively blocking the interaction with other proteins contain-
ing the RGD sequence [25]. For this purpose, L1-de¢cient
¢broblasts were transfected with GIRK1/4-GFP WT con-
structs and incubated in the presence of 0.5 mM RGDS pep-
tide for 2 days, and the distribution of GIRK1/4 channels in
the ¢broblasts was examined with the confocal microscope. In
spite of the presence of RGDS peptide, GIRK1/4 channels
were localized to the plasma membranes (data not shown).
Whole-cell current measurements showed that the incubation
with 0.4 mM RGDS peptide did not a¡ect basal or ACh-
induced GIRK currents (Fig. 3) (the peptide was added to
all external solutions 1 h after the DNA transfection and
remained in the solution throughout the experiment).
Fig. 3. KCl and ACh-induced GIRK current from L1-null ¢bro-
blasts in the presence and absence of extracellular RGD peptide
(0.4 mM). Currents were measured at day 2 after cotransfection of
CHO cells with the GIRK1/GIRK4 heteromultimer channel and a
GFP reporter plasmid. Measurements were made as in Fig. 2. Data
represent mean þ S.E.M. of six (with RGD peptide) and seven (con-
trol) cells from two independent experiments.
Fig. 4. Speci¢city of the antibody to integrin L1, examined with
[35S]methionine-labeled GIRK1/4 protein, translated in vitro in rab-
bit reticulocyte lysate. Lane 1, immunoprecipitation of GIRK1/4
with antibody to integrin L1. The antibody to integrin L1 does not
recognize GIRK1/4 protein. Lane 2, immunoprecipitation 35S-la-
beled GIRK1/4 channel expressed in lysate, using antibody to C-ter-
minus of GIRK1. Lanes 3 and 4, GIRK1/4 translated in reticulo-
cyte lysate. Each lane was loaded with 5 Wl of lysate.
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3.4. Co-immunoprecipitation of L1 integrins and GIRK1/4 WT
and GIRK1/4(RGDCRGE) mutant channels
The interaction between L1 integrins and GIRK1/4 WT and
double mutant GIRK1/4 channels was examined in Xenopus
oocytes. First, to examine whether the antibody against L1
integrin recognizes GIRK1 or GIRK4 proteins, we expressed
the GIRK1/4 channel in vitro in the rabbit reticulocyte lysate
and immunoprecipitated the solubilized channel with antibod-
ies for GIRK1 and for L1 integrin separately. As shown in
Fig. 4 (lane 1), the L1 integrin antibody did not immunopre-
cipitate the GIRK1/4 channel, whereas the GIRK1 antibody
did.
Oocytes were injected with cRNAs and metabolically la-
beled by incubation for 3 days in medium containing
[35S]methionine. The channels were isolated separately from
plasma membranes and from the rest of the cell (internal
fraction) by detergent solubilization, followed by immunopre-
cipitation, and subjected to SDS^PAGE and autoradiogra-
phy. To study the interaction of GIRK1/4 WT and GIRK1/
4(RGDCRGE) mutant channels with the Xenopus oocyte
endogenous L1 integrins, we carried out co-immunoprecipita-
tion using the antibody to the C-terminus of L1 integrin. In
the same experiments, using the antibody against the C-termi-
nus of GIRK1, we immunoprecipitated the GIRK1/4 chan-
nels to examine the levels of expression of WT and
RGDCRGE mutant channels. Autoradiograms of typical
gels are shown in Fig. 5A and B. Data presented in these
¢gures were obtained in the same batch of oocytes. As shown
previously, the immunoprecipitated GIRK1 protein migrated
as a doublet of 58^56 kDa, and GIRK4 ran as a band at
45 kDa. The WT GIRK1 also has a di¡use band of approx-
imately 80 kDa, which represents a heavily glycosylated form
of the protein [26]. The level of expression of GIRK1/4 WT
and GIRK1/4(RGDCRGE) mutant in the internal fraction
was equal. In the plasma membrane fraction, the
RGDCRGE mutants were found in much smaller amounts
than the WT proteins, and the GIRK1(RGDCRGE) mutant
also lacked the glycosylated form (Fig. 5A, lane 5). Band
intensities were measured in three experiments using a Phos-
phorImager. In all experiments, the major di¡erence between
WT and RGDCRGE mutant channels was the absence of a
glycosylated form in the GIRK1(RGDCRGE) mutant ex-
pressed in the plasma membrane. The amount of GIRK1
subunit mutants in the plasma membrane was 3 times less
than that of the 58^56 kDa unglycosylated form of the WT
protein.
Fig. 5B shows the results of co-immunoprecipitation of
GIRK WT and mutant, using the antibody against L1 integ-
rin. We observed co-immunoprecipitation of both GIRK1/4
WT and GIRK1/4 mutant. Again there was less GIRK1/4
intensity in the plasma membrane fraction from the oocytes
expressing the RGDCRGE mutant, and the glycosylated
form was essentially absent in the plasma membrane fraction.
These results show that the RGD sequences are not essential
for the interaction between GIRK1/4 and L1 integrins.
Two-electrode voltage-clamp recordings were made 3 days
after RNA injection (m2R was coexpressed in all cases). One
WM ACh, which stimulated large current via the WT GIRK1/
4 channels, produced no detectable current in oocytes express-
ing the GIRK1/4(RGDCRGE) mutant (data not shown), in
con¢rmation of previous data [19].
4. Discussion
In the present study we provide evidence that, despite the
interaction between inward recti¢er GIRK1/4 channels and L1
integrins, these channels do not require L1 integrins for their
expression and function. Moreover, we have shown that the
RGD sequences of GIRK1 and GIRK4 channels are not es-
sential for the interaction with L1 integrins. The RGDCRGE
mutations result in loss of the GIRK1/4 function, apparently
because proper channel processing and/or plasma targeting is
disrupted. The mechanism of this crucial dependence on the
conserved aspartate residue is unknown.
Confocal immuno£uorescence microscopy analysis revealed
no alterations in the distribution of GIRK1/4 protein in L1-
null ¢broblasts compared with cells expressing the L1A splice
variant. The magnitude of the current in the two cell lines was
not signi¢cantly di¡erent. These cells express K5L1, K6L1, and
perhaps other KL1A combinations. The possibility that other
integrins (KvL3 and KvL5) present in the L1-de¢cient cells
replaced the L1 integrin was addressed in part by experiments
with an externally applied RGDS-containing peptide, which is
expected to compete with GIRK channels for the extracellular
interaction with integrins. The peptide a¡ected neither the
cellular distribution of the GIRK proteins nor the amplitude
of basal and agonist-evoked GIRK currents. Thus, expression
Fig. 5. SDS^PAGE analysis of immunoprecipitated GIRK1 and
GIRK4 polypeptides expressed in cRNA-injected oocytes metabol-
ically labeled with [35S]methionine. A: Co-immunoprecipitation of
GIRK1 and GIRK4 protein with antibody to GIRK1. B: Co-im-
munoprecipitation of endogenous L1 integrin and GIRK1 and
GIRK4 with antibody to L1 integrin. In each lane, immunoprecipi-
tates from 30 plasma membranes and 30 internal oocyte fractions
were loaded. For both panels, lanes 1 and 4 contained immunopre-
cipitates from oocytes injected with GIRK1/4 cRNA; lanes 2 and 5
contained immunoprecipitates from oocytes injected with GIRK1/
4(RGDCRGE) mutant cRNA; lanes 3 and 6 contained immuno-
precipitates from uninjected oocytes.
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and function of GIRK1/4 channels is not dependent on any
RGD-mediated interaction that could be disrupted by exter-
nally applied peptide, with L1 or any other integrins present in
GD10 cells. In control ¢broblasts, L1-null ¢broblasts, and
oocytes, the GIRK(RGDCRGE) mutant was not expressed
in the plasma membrane.
Results obtained in co-immunoprecipitation experiments in
Xenopus oocytes showed that the endogenous L1 integrin in-
teracts with GIRK1/4 WT, in agreement with earlier observa-
tions [19]. However, in contrast to the above work, we also
observed interaction between L1 integrins and GIRK mutant
RGDCRGE in the internal fraction and to some extent in
the plasma membranes. This discrepancy may re£ect di¡er-
ences in the level of expression of the GIRK1/4 WT and
GIRK1/4(RGDCRGE) mutant present in the previously de-
scribed co-immunoprecipitation experiments [19]. Our results
demonstrate that the RGD sequences in GIRK1/4 are not
essential for the interaction with L1 integrins.
It should be noted that, in Xenopus oocytes, we found no
di¡erence in the expression between WT and mutant
RGDCRGE of GIRK in the internal fraction. However,
the amount of the WT channels in plasma membranes was
3-fold greater than for the mutant channels. As mentioned
above, the GFP-tagged GIRK1/4(RGDCRGE) mutant did
not reach the plasma membrane in ¢broblasts expressing L1
integrins. McPhee et al. [19] also observed that the
RGDCRGE mutation decreased the quantities of the
GIRK protein reaching the plasma membrane in Xenopus
oocytes. McPhee et al. suggested that GIRK channels require
L1 integrins for plasma membrane expression, and that muta-
tion disrupts this interaction. However, the present results
indicate that it is more likely that the RGDCRGE mutations
cause inappropriate processing and/or tra⁄cking of the GIRK
protein via another, unknown mechanism. Interestingly, the
RGDCRGE mutant did not have a glycosylated form in the
plasma membrane. However, the absence of glycosylation
alone cannot explain the loss of function, since the removal
of the glycosylated site in GIRK1 does not a¡ect GIRK func-
tion [27].
Our results are in agreement with a recently published work
[28] showing that precursor convertase 1 containing a con-
served RGD sequence interacts with K5L1 integrin in an
RGD-independent manner. The authors suggest that the
RGD motif of preprotein convertase 1 is critical for its cellu-
lar tra⁄cking but not for its intracellular binding to integrin
K5L1.
It should be noted that, although the RGD sequences are
present only in GIRK but not in other K channels, similar
motifs are found in other inward recti¢ers at the same posi-
tion. The motif is HGD and other sequences; however, all
inwardly rectifying K channels have a conserved aspartate
residue in this region. It was shown [29] that replacing this
conserved aspartate for histidine in an HKD motif (which is
not a recognition site for integrins) in Kir1.1 resulted in a
complete loss of channel function. Perhaps only the aspartate
residue, but not the entire RGD motif, is important for prop-
er channel function.
Based on the above results, we conclude that (1) inward
recti¢er heterotetrameric GIRK1/GIRK4 channels do not re-
quire L1 integrins for expression and function; (2) the RGD
motif, and possibly mainly the conserved aspartate residue, is
important for proper GIRK processing; and (3) intact RGD
motifs are not essential for interaction of GIRK1 and GIRK4
channels with L1 integrins. The region responsible for this
interaction has not been identi¢ed, and the functional conse-
quences of GIRK1/4 binding to L1 integrins remain uncertain.
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